Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
IONIS-BIIB6
- Development stage
- Unknown
- Lead developer
- Biogen
- Modality
- Antisense Oligonucleotides (ASOs) → Long RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Modified DNA Oligonucleotides → Antisense DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Single-strand DNA → Antisense DNA → DNA Therapeutics → Nucleic Acid Therapeutics
01
Overview
IONIS-BIIB6 is an investigational antisense oligonucleotide drug developed through a collaboration between Ionis Pharmaceuticals and Biogen[1]. Its precise mechanism, molecular target, and indication remain undisclosed in public sources, though it is listed alongside other Ionis antisense oligonucleotides for neurodegenerative disorders[1]. Antisense oligonucleotides act by binding to target RNA sequences and modulating gene expression, typically leading to the reduction of pathogenic protein(s). The context of development suggests a potential application in neurological or neurodegenerative disease, consistent with other drugs from the collaboration. No data regarding structure, clinical phase, or experimental results for IONIS-BIIB6 has been publicly released.
- Brand names
- IONIS-BIIB6IONIS-BIIB-6IONIS-BIIB 6
- Other names
- IONIS-BIIB6IONIS-BIIB-6IONIS-BIIB 6
Beyond the preview
Go deeper on IONIS-BIIB6.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on IONIS-BIIB6.